Pradaxa User's Labeling Claims Preempted, Calif. Judge Rules
A California state judge on Friday handed Boehringer Ingelheim Pharmaceuticals a big win in consolidated litigation over its blood thinner Pradaxa, finding that federal law preempts a woman's claims that the...To view the full article, register now.
Already a subscriber? Click here to view full article